CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
Universidad Pablo de Olavide
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Universidad Pablo de Olavide (4)
2024
2023
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
2021
-
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39